T. Rowe Price Associates
CNS icon

T. Rowe Price Associates’s Cohen & Steers CNS Stock Holding History

T. Rowe Price Associates’s Portfolio CNS Stock Details CNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.06M Buy
32,944
+4,010
+14% +$262K ﹤0.01% 1809
2025
Q4 		$1.82M Buy
28,934
+4,863
+20% +$316K ﹤0.01% 1797
2025
Q3 		$1.58M Buy
24,071
+1,099
+5% +$80.5K ﹤0.01% 1834
2025
Q2 		$1.73M Buy
22,972
+1,655
+8% +$127K ﹤0.01% 1703
2025
Q1 		$1.71M Buy
21,317
+4,385
+26% +$374K ﹤0.01% 1683
2024
Q4 		$1.56M Sell
16,932
-863
-5% -$85.4K ﹤0.01% 1766
2024
Q3 		$1.71M Buy
17,795
+253
+1% +$21.5K ﹤0.01% 1713
2024
Q2 		$1.27M Buy
17,542
+1,322
+8% +$94K ﹤0.01% 1782
2024
Q1 		$1.25M Buy
16,220
+941
+6% +$67.2K ﹤0.01% 1806
2023
Q4 		$1.16M Buy
15,279
+431
+3% +$25.9K ﹤0.01% 1794
2023
Q3 		$931K Buy
14,848
+242
+2% +$15.3K ﹤0.01% 1829
2023
Q2 		$848K Buy
14,606
+331
+2% +$19.3K ﹤0.01% 1886
2023
Q1 		$914K Buy
14,275
+434
+3% +$30.3K ﹤0.01% 1833
2022
Q4 		$894K Sell
13,841
-58
-0.4% -$3.64K ﹤0.01% 1833
2022
Q3 		$871K Sell
13,899
-6,628
-32% -$474K ﹤0.01% 1828
2022
Q2 		$1.3M Sell
20,527
-3,589
-15% -$271K ﹤0.01% 1769
2022
Q1 		$2.07M Buy
24,116
+2,981
+14% +$247K ﹤0.01% 1676
2021
Q4 		$1.96M Sell
21,135
-124
-0.6% -$11.5K ﹤0.01% 1718
2021
Q3 		$1.78M Buy
21,259
+258
+1% +$21.9K ﹤0.01% 1781
2021
Q2 		$1.72M Sell
21,001
-931
-4% -$67.2K ﹤0.01% 1802
2021
Q1 		$1.43M Buy
21,932
+2
+0% +$137 ﹤0.01% 1867
2020
Q4 		$1.63M Buy
21,930
+3,221
+17% +$213K ﹤0.01% 1712
2020
Q3 		$1.04M Buy
18,709
+5,247
+39% +$324K ﹤0.01% 1779
2020
Q2 		$916K Sell
13,462
-4,871
-27% -$294K ﹤0.01% 1826
2020
Q1 		$833K Buy
18,333
+3,396
+23% +$215K ﹤0.01% 1783
2019
Q4 		$937K Buy
14,937
+904
+6% +$57.2K ﹤0.01% 1910
2019
Q3 		$771K Sell
14,033
-4,597
-25% -$243K ﹤0.01% 1924
2019
Q2 		$958K Sell
18,630
-13,941
-43% -$684K ﹤0.01% 1858
2019
Q1 		$1.38M Buy
32,571
+70
+0.2% +$2.72K ﹤0.01% 1716
2018
Q4 		$1.11M Buy
32,501
+37
+0.1% +$1.37K ﹤0.01% 1757
2018
Q3 		$1.32M Sell
32,464
-66
-0.2% -$2.77K ﹤0.01% 1758
2018
Q2 		$1.36M Buy
32,530
+38
+0.1% +$1.53K ﹤0.01% 1713
2018
Q1 		$1.32M Sell
32,492
-3,258
-9% -$137K ﹤0.01% 1689
2017
Q4 		$1.69M Sell
35,750
-10
-0% -$440 ﹤0.01% 1628
2017
Q3 		$1.41M Sell
35,760
-1,074,670
-97% -$42.7M ﹤0.01% 1671
2017
Q2 		$45M Buy
1,110,430
+5,590
+0.5% +$223K 0.01% 863
2017
Q1 		$44.2M Sell
1,104,840
-24,230
-2% -$877K 0.01% 852
2016
Q4 		$37.9M Buy
1,129,070
+4,570
+0.4% +$167K 0.01% 910
2016
Q3 		$48.1M Sell
1,124,500
-17,170
-2% -$726K 0.01% 818
2016
Q2 		$46.2M Sell
1,141,670
-3,970
-0.3% -$156K 0.01% 812
2016
Q1 		$44.6M Sell
1,145,640
-11,100
-1% -$349K 0.01% 810
2015
Q4 		$35.3M Buy
1,156,740
+15,270
+1% +$459K 0.01% 893
2015
Q3 		$31.3M Buy
1,141,470
+3,480
+0.3% +$107K 0.01% 941
2015
Q2 		$38.8M Sell
1,137,990
-3,500
-0.3% -$132K 0.01% 927
2015
Q1 		$46.7M Buy
1,141,490
+9,200
+0.8% +$392K 0.01% 867
2014
Q4 		$47.6M Buy
1,132,290
+7,200
+0.6% +$301K 0.01% 855
2014
Q3 		$43.2M Sell
1,125,090
-1,300
-0.1% -$55.2K 0.01% 884
2014
Q2 		$48.9M Sell
1,126,390
-5,100
-0.5% -$209K 0.01% 875
2014
Q1 		$45.1M Sell
1,131,490
-4,400
-0.4% -$166K 0.01% 892
2013
Q4 		$45.5M Buy
1,135,890
+1,890
+0.2% +$72.7K 0.01% 871
2013
Q3 		$40M Sell
1,134,000
-64,700
-5% -$2.24M 0.01% 903
2013
Q2 		$40.7M Buy
+1,198,700
New +$45.5M 0.01% 848

Other funds holding CNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

T. Rowe Price Associates's CNS Position: Q1 2026 in Review

T. Rowe Price Associates increased its Cohen & Steers (CNS) stake by 14% in Q1 2026, buying an estimated $262K and bringing the position to 32,944 shares worth $2.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

T. Rowe Price Associates first reported a position in CNS in Q2 2013 and has held it in 52 quarters since. The position peaked at $48.9M in Q2 2014. 294 funds tracked by Wall St. Rank hold CNS as of Q1 2026.

  • T. Rowe Price Associates held 32,944 shares of Cohen & Steers worth $2.06M as of Q1 2026.
  • T. Rowe Price Associates bought 4,010 Cohen & Steers shares in Q1 2026, an estimated $262K.
  • Cohen & Steers made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1809 holding.
  • T. Rowe Price Associates first reported a position in Cohen & Steers in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Cohen & Steers position peaked at $48.9M in Q2 2014.
  • 294 funds tracked by Wall St. Rank held Cohen & Steers as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.